NovaBridge Biosciences (NBP) Gains from Investment Securities (2025)
NovaBridge Biosciences' Gains from Investment Securities was -$14.66 million in Q4 2025.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Gains from Investment Securities (2025) Analysis & Trends
For FY2025, Gains from Investment Securities at NovaBridge Biosciences came in at -$5.16 million.
- In earlier years, Gains from Investment Securities was -$3.73 million in FY2023, $1.96 million in FY2022 and -$4.71 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | NovaBridge Biosciences | 99.23 Mn | -696.35 Mn | - |
API Access
NovaBridge Biosciences Gains from Investment Securities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=NBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-investment-securities", "ticker": "NBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=NBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();